These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26055425)

  • 1. The 3q29 deletion confers >40-fold increase in risk for schizophrenia.
    Mulle JG
    Mol Psychiatry; 2015 Sep; 20(9):1028-9. PubMed ID: 26055425
    [No Abstract]   [Full Text] [Related]  

  • 2. Study protocol for The Emory 3q29 Project: evaluation of neurodevelopmental, psychiatric, and medical symptoms in 3q29 deletion syndrome.
    Murphy MM; Lindsey Burrell T; Cubells JF; España RA; Gambello MJ; Goines KCB; Klaiman C; Li L; Novacek DM; Papetti A; Sanchez Russo RL; Saulnier CA; Shultz S; Walker E; Mulle JG
    BMC Psychiatry; 2018 Jun; 18(1):183. PubMed ID: 29884173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3q29 microdeletion syndrome: Cognitive and behavioral phenotype in four patients.
    Città S; Buono S; Greco D; Barone C; Alfei E; Bulgheroni S; Usilla A; Pantaleoni C; Romano C
    Am J Med Genet A; 2013 Dec; 161A(12):3018-22. PubMed ID: 24214349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric phenotypes and a distinct constellation of ASD features in 3q29 deletion syndrome: results from the 3q29 registry.
    Pollak RM; Murphy MM; Epstein MP; Zwick ME; Klaiman C; Saulnier CA; ; Mulle JG
    Mol Autism; 2019; 10():30. PubMed ID: 31346402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric-disorder-related behavioral phenotypes and cortical hyperactivity in a mouse model of 3q29 deletion syndrome.
    Baba M; Yokoyama K; Seiriki K; Naka Y; Matsumura K; Kondo M; Yamamoto K; Hayashida M; Kasai A; Ago Y; Nagayasu K; Hayata-Takano A; Takahashi A; Yamaguchi S; Mori D; Ozaki N; Yamamoto T; Takuma K; Hashimoto R; Hashimoto H; Nakazawa T
    Neuropsychopharmacology; 2019 Nov; 44(12):2125-2135. PubMed ID: 31216562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric phenotype in relation to gene variants in the hemizygous allele in 3q29 deletion carriers: A case series.
    Malt EA; Juhasz K; Frengen A; Wangensteen T; Emilsen NM; Hansen B; Agafonov O; Nilsen HL
    Mol Genet Genomic Med; 2019 Sep; 7(9):e889. PubMed ID: 31347308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive phenotyping of neuropsychiatric traits in a multiplex 3q29 deletion family: a case report.
    Murphy MM; Burrell TL; Cubells JF; Epstein MT; Espana R; Gambello MJ; Goines K; Klaiman C; Koh S; Russo RS; Saulnier CA; Walker E; ; Mulle JG
    BMC Psychiatry; 2020 Apr; 20(1):184. PubMed ID: 32321479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NCBP2 modulates neurodevelopmental defects of the 3q29 deletion in Drosophila and Xenopus laevis models.
    Singh MD; Jensen M; Lasser M; Huber E; Yusuff T; Pizzo L; Lifschutz B; Desai I; Kubina A; Yennawar S; Kim S; Iyer J; Rincon-Limas DE; Lowery LA; Girirajan S
    PLoS Genet; 2020 Feb; 16(2):e1008590. PubMed ID: 32053595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EEG findings in a pediatric patient with 3q29 microdeletion syndrome.
    Sheikh IS; Nascimento FA; Waite SR; Lam AD
    Epileptic Disord; 2024 Feb; 26(1):151-153. PubMed ID: 37767975
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecular characterisation and phenotypic description of two patients with reciprocal chromosomal aberrations in the region of the 3q29 microdeletion/microduplication syndromes].
    Quintela I; Barros-Angueira F; Perez-Gay L; Dacruz D; Castro-Gago M; Carracedo A; Eiris-Punal J
    Rev Neurol; 2015 Sep; 61(6):255-60. PubMed ID: 26350776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical case report and literature review of the 3q29 microdeletion syndrome.
    Cox DM; Butler MG
    Clin Dysmorphol; 2015 Jul; 24(3):89-94. PubMed ID: 25714563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New phenotypes associated with 3q29 duplication syndrome: Results from the 3q29 registry.
    Pollak RM; Zinsmeister MC; Murphy MM; Zwick ME; ; Mulle JG
    Am J Med Genet A; 2020 May; 182(5):1152-1166. PubMed ID: 32154651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial inheritance of the 3q29 microdeletion syndrome: case report and review.
    Khan WA; Cohen N; Scott SA; Pereira EM
    BMC Med Genomics; 2019 Mar; 12(1):51. PubMed ID: 30885185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral changes and growth deficits in a CRISPR engineered mouse model of the schizophrenia-associated 3q29 deletion.
    Rutkowski TP; Purcell RH; Pollak RM; Grewenow SM; Gafford GM; Malone T; Khan UA; Schroeder JP; Epstein MP; Bassell GJ; Warren ST; Weinshenker D; Caspary T; Mulle JG
    Mol Psychiatry; 2021 Mar; 26(3):772-783. PubMed ID: 30976085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders.
    Rutkowski TP; Schroeder JP; Gafford GM; Warren ST; Weinshenker D; Caspary T; Mulle JG
    J Neurosci Res; 2017 May; 95(5):1144-1160. PubMed ID: 27859486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxysmal oculogyric dystonia associated with a de novo 3q29 microdeletion.
    Kaur H; Thom RP; Neumeyer AM; Bilancia CG; Wray SH; McDougle CJ
    Psychiatr Genet; 2020 Aug; 30(4):119-123. PubMed ID: 32459710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying a failure-to-thrive fraternal twin profile with 3q29 deletion syndrome.
    Capps C; Nemeth DG; Olivier TW; Felix SD
    Appl Neuropsychol Child; 2024; 13(1):84-91. PubMed ID: 37480577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of the schizophrenia-associated 3q29 deletion.
    Pollak RM; Purcell RH; Rutkowski TP; Malone T; Pachura KJ; Bassell GJ; Epstein MP; Dawson PA; Smith MR; Jones DP; Zwick ME; Warren ST; Caspary T; Weinshenker D; Mulle JG
    Transl Psychiatry; 2022 Feb; 12(1):66. PubMed ID: 35177588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel 3q29 deletion associated with autism, intellectual disability, psychiatric disorders, and obesity.
    Biamino E; Di Gregorio E; Belligni EF; Keller R; Riberi E; Gandione M; Calcia A; Mancini C; Giorgio E; Cavalieri S; Pappi P; Talarico F; Fea AM; De Rubeis S; Cirillo Silengo M; Ferrero GB; Brusco A
    Am J Med Genet B Neuropsychiatr Genet; 2016 Mar; 171B(2):290-9. PubMed ID: 26620927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment-resistant psychotic symptoms and early-onset dementia: A case report of the 3q29 deletion syndrome.
    Harner MK; Lichtenstein M; Farrell M; Dietterich TE; Filmyer DM; Bruno LM; Biondi TF; Crowley JJ; Lázaro-Muñoz G; Stowe R; Shaughnessy RA; Berg JS; Szatkiewicz J; Sullivan PF; Josiassen RC
    Schizophr Res; 2020 Oct; 224():195-197. PubMed ID: 32943312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.